6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amar, M; Brunelle, A; Debortoli, L; Ferrié, L; Figadère, B; Kadar, H; Latini, A; Le Douaron, G; Michel, PP; Raisman-Vozari, R; Schmidt, F; Séon-Méniel, B; Touboul, D | 1 |
| Aktumsek, A; Alcaro, S; Bagetta, D; Carradori, S; De Monte, C; De Vita, D; Guglielmi, P; Ortuso, F; Petzer, A; Petzer, JP; Secci, D; Zengin, G | 1 |
| Ahmad, R; Ali, J; Atiq, A; Choe, K; Kang, MH; Khan, A; Kim, MO; Lee, HJ; Park, JS; Rehman, IU; Tahir, M | 1 |
| Beyrath, J; Boschian, C; Ferraiuolo, L; Lopes, FM; Mortiboys, H; Myszczynska, MA; New, EJ; Schwartzentruber, A; Smeitink, J | 1 |
| Ehrhart, J; Zeevalk, GD | 2 |
6 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
Topics: Animals; Brain; Cell Culture Techniques; Cells, Cultured; Dopaminergic Neurons; Male; Mice, Inbred C57BL; Molecular Structure; Neuroprotective Agents; Parkinson Disease; Quantitative Structure-Activity Relationship; Quinoxalines; Rats, Sprague-Dawley; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tissue Distribution | 2015 |
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
Topics: Acetylcholinesterase; Animals; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Horses; Humans; Hydrazones; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Structure-Activity Relationship | 2018 |
Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Motor Disorders; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase; Vitamin E | 2023 |
Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons.
Topics: Adult; Cell Death; Chromans; Dopaminergic Neurons; Female; Humans; Male; Middle Aged; Mitochondria; Mitophagy; Optical Imaging; Oxidation-Reduction; Parkinson Disease; Ubiquitin-Protein Ligases | 2020 |
Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures.
Topics: Animals; Antioxidants; Ascorbic Acid; Buthionine Sulfoximine; Chromans; Disulfides; Fluorescent Dyes; Glutathione; Glutathione Disulfide; Malonates; Mesencephalon; Mitochondria; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2003 |
Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures.
Topics: Amitrole; Animals; Antioxidants; Ascorbic Acid; Catalase; Cells, Cultured; Chromans; Energy Metabolism; Enzyme Inhibitors; Glutathione Disulfide; Hydrogen Peroxide; Malonates; Mesencephalon; Neurons; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2001 |